S-1/A: Cantor Equity Partners IV Launches $400M IPO Amid Dilution Concerns

Sentiment:

Initial Public Offering (IPO) Prospectus


Cantor Equity Partners IV, Inc., a blank check company, is launching an initial public offering of 40 million Class A ordinary shares at $10.00 each to pursue business combinations in financial services, digital assets, healthcare, real estate, technology, and software.

Capital raiseThe company is conducting an initial public offering of 40,000,000 Class A ordinary shares at $10.00 per share, with an over-allotment option for up to 6,000,000 additional shares.The sponsor, Cantor EP Holdings IV, LLC, will purchase 900,000 Class A ordinary shares in a private placement for $9,000,000 concurrently with the IPO.The sponsor has committed up to $1,750,000 in non-interest bearing working capital loans, convertible into Class A ordinary shares at $10.00 per share no earlier than 60 days after the offering date.The company may seek additional financing (debt or equity) to complete its initial business combination or fund the operations/growth of a target business, which could cause material dilution to existing shareholders.
Worse than expectedPublic shareholders will incur immediate and substantial dilution of approximately 100.1% ($10.01 per share) due to the sponsor's nominal purchase price for founder shares ($0.002 per share).The pro forma net tangible book value per share after the offering is $(0.01), which is significantly below the $10.00 offering price.Several prior SPACs sponsored by Cantor affiliates (CFAC II, CFAC III, CFAC V, CFAC VIII, CFAC IV, CFAC VII) experienced very high redemption rates (up to 97.2%) or liquidation, indicating poor outcomes for public shareholders in those instances.The company has a working capital deficiency of $(155,650) and a shareholders deficit of $(44,385) as of June 30, 2025, prior to the IPO, highlighting its pre-IPO financial instability.

Summary

  • The company is offering 40,000,000 Class A ordinary shares at an initial public offering price of $10.00 per share, aiming to raise $400,000,000.
  • Underwriters have a 45-day option to purchase up to an additional 6,000,000 Class A ordinary shares to cover over-allotments.
  • Cantor EP Holdings IV, LLC, the sponsor, will purchase 900,000 private placement shares for $9,000,000 concurrently with the IPO.
  • A total of $400,000,000 (or $460,000,000 if the over-allotment option is fully exercised) will be deposited into a trust account for the purpose of effecting an initial business combination.
  • The company has 24 months from the closing of the offering to consummate its initial business combination.
  • Target industries for potential acquisitions include financial services, digital assets, healthcare, real estate services, technology, and software.
  • As of June 30, 2025, the company reported a working capital deficiency of $(155,650) and a total shareholders deficit of $(44,385).
  • Net loss for the three months ended June 30, 2025, was $(15,355), and for the six months ended June 30, 2025, was $(42,503).

Sentiment

Score: 3

Explanation: The filing outlines a standard SPAC IPO with an experienced sponsor, but the significant immediate dilution for public shareholders, the sponsor's minimal cost basis, and the poor historical performance (high redemptions, liquidations) of several affiliated SPACs create substantial risks and suggest a less favorable outlook for public investors compared to the sponsor.

Positives

  • The management team and its affiliates have extensive experience in sourcing, structuring, acquiring, and selling businesses, with Cantor and its affiliates having acquired over 75 companies since 2005.
  • The company intends to leverage the substantial resources and global infrastructure of Cantor Fitzgerald, L.P., which is a diversified financial and real estate services provider.
  • The investment strategy is focused on industries where the management team and affiliates have expertise, including high-growth sectors like digital assets and technology.
  • The company's structure, which does not include warrants, aims to reduce the dilutive effect on public shareholders upon completion of a business combination compared to many other SPACs.
  • The sponsor has committed to providing up to $1,750,000 in non-interest bearing working capital loans and up to $300,000 for offering expenses, demonstrating financial commitment.

Negatives

  • Public shareholders will experience immediate and substantial dilution of approximately 100.1% (or $10.01 per share) due to the sponsor's acquisition of founder shares at a nominal price of approximately $0.002 per share.
  • Significant conflicts of interest exist due to the management team's affiliations with Cantor and other 'Active Cantor SPACs,' potentially diverting attractive business opportunities.
  • The sponsor's minimal cost basis for founder shares creates a strong economic incentive to complete a business combination, even if it is with a riskier or less-established target that may be unprofitable for public shareholders.
  • The company has no operating history or revenues, making it difficult for investors to evaluate its ability to achieve its business objective.
  • There is a risk of not completing an initial business combination within the 24-month timeframe, which would lead to liquidation and public shareholders potentially receiving less than their initial investment.
  • The company may be deemed an investment company under the Investment Company Act, which could impose burdensome compliance requirements or necessitate liquidation.
  • High redemption rates in several prior Cantor-affiliated SPACs (e.g., CFAC III at 84.2%, CFAC V at 92.6%, CFAC VIII at 97.2%) indicate a history of unfavorable outcomes for public shareholders in similar ventures.
  • The company may be subject to a 1% U.S. federal excise tax on redemptions if it domesticates to a U.S. state corporation, further reducing returns for public shareholders.

Risks

  • Public shareholders may not be afforded an opportunity to vote on the proposed initial business combination, meaning it could be completed even if a majority of public shareholders do not support it.
  • The ability of public shareholders to exercise redemption rights with a large number of shares may make the company's financial condition unattractive to potential business combination targets, hindering the ability to complete a desirable transaction.
  • Failure to complete an initial business combination within the prescribed 24-month timeframe will result in the company ceasing operations, redeeming public shares, and liquidating, potentially returning less than $10.00 per share to public shareholders.
  • Adverse developments affecting the financial services industry, including liquidity issues or defaults by financial institutions, could impair the value of assets held in the trust account.
  • Current global geopolitical conditions, such as armed conflicts and sanctions, may materially adversely affect the search for an initial business combination and the operations of any target business.
  • Increased competition from other SPACs and entities for attractive target businesses may raise acquisition costs or make it more difficult to find and consummate an initial business combination.
  • Changes in the market for directors and officers liability insurance could make it more difficult and expensive to negotiate and complete an initial business combination.
  • Pursuing business combination opportunities with a high degree of complexity or requiring significant operational improvements could delay or prevent the achievement of desired results.
  • Purchases of public shares by initial shareholders, directors, officers, or their affiliates may influence a vote on a proposed business combination and reduce the public float of Class A ordinary shares.
  • Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
  • If funds outside the trust account and committed working capital loans are insufficient, the company may be unable to complete its initial business combination.
  • Subsequent to the completion of an initial business combination, the company may be required to take write-downs, write-offs, restructuring, or impairment charges that could negatively affect financial condition and share price.
  • If third parties bring claims against the company, the proceeds held in the trust account could be reduced, leading to a per-share redemption amount less than $10.00.
  • The company may not have sufficient funds to satisfy indemnification claims of its directors and officers.
  • If a bankruptcy or winding-up petition is filed, a court may seek to recover proceeds distributed to shareholders, and the board may face claims of punitive damages.
  • The company may seek business combination opportunities in industries or sectors outside of management's area of expertise, increasing risk.
  • The company may complete a business combination with a target that does not meet its identified general criteria, potentially leading to less successful outcomes.
  • Combining with an early-stage or financially unstable business could lead to volatile revenues, cash flows, or earnings, or difficulty retaining key personnel.
  • The company is not required to obtain an independent fairness opinion for non-affiliated business combinations, meaning shareholders rely solely on the board's judgment.
  • Compliance obligations under the Sarbanes-Oxley Act may increase the difficulty, time, and costs of effectuating an initial business combination.
  • The absence of a specified maximum redemption threshold may allow the company to complete a business combination even if a substantial majority of shareholders disagree.
  • The provisions of the company's amended and restated memorandum and articles of association related to pre-business combination activity can be amended with a special resolution (two-thirds vote), potentially facilitating a business combination that some shareholders do not support.
  • The company may be unable to obtain additional financing to complete an initial business combination or fund the operations and growth of a target business, potentially compelling restructuring or abandonment.
  • Initial shareholders control director appointments until after the business combination and hold a substantial interest, potentially influencing actions in a manner not supported by public shareholders.
  • An initial business combination may be subject to regulatory review and approval requirements (e.g., CFIUS), which could delay or prohibit the transaction.
  • The company may only complete one business combination, leading to a lack of diversification and dependence on a single business's performance.
  • The company is dependent upon its officers and directors, and their departure could adversely affect its ability to operate.
  • The nominal purchase price paid by the sponsor for founder shares creates an incentive for the sponsor to complete a business combination even if it causes the trading price of ordinary shares to materially decline.
  • Changes in laws or regulations, or failure to comply, may adversely affect the business, including the ability to complete an initial business combination.
  • If deemed an investment company under the Investment Company Act, the company may face burdensome compliance requirements and restricted activities.
  • If a shareholder or group holds more than 15% of Class A ordinary shares and a shareholder vote is held, they will lose the ability to redeem shares in excess of 15%.
  • Nasdaq may delist Class A ordinary shares, limiting liquidity and subjecting the company to additional trading restrictions.
  • The founder shares may adversely affect the market price of Class A ordinary shares and make it more difficult to effectuate an initial business combination.
  • As a controlled company under Nasdaq rules, the company may utilize exemptions from certain corporate governance requirements, reducing protections for shareholders.
  • An investment may result in uncertain or adverse U.S. federal income tax consequences, including potential PFIC status.
  • The company's amended and restated memorandum and articles of association designate Cayman Islands courts as exclusive forums for certain disputes, potentially limiting shareholders' ability to seek remedies in U.S. federal courts.
  • Risks related to digital assets include regulatory uncertainty, varying global interpretations, potential for more onerous regulation, and high uncertainty in industry growth.
  • Risks related to the healthcare industry include competition, compliance with governmental regulations, intellectual property rights, maintaining secure infrastructure, product approval delays, cost containment efforts, seasonality, liability exposure, and dependence on third-party suppliers.
  • Risks related to the software and technology industries include failure to develop new products, inability to grow user base, significant competition, network disruptions, cybersecurity threats, and intellectual property protection.

Future Outlook

The company is a blank check company with no operating history or revenues, and its future outlook is entirely dependent on successfully identifying and consummating an initial business combination within 24 months. It expects to incur increased expenses as a public company and while conducting due diligence for potential targets. The company intends to leverage its management team's and Cantor's affiliates' expertise and network to identify target businesses in financial services, digital assets, healthcare, real estate services, technology, and software industries. There is no assurance that a suitable target will be found or that a business combination will be successful or profitable for public shareholders.

Management Comments

  • "We believe that the combination of our management teams and our affiliates financial services, financial and real estate technology, and real estate industry expertise and proven ability to grow businesses through acquisitions make us uniquely qualified to pursue acquisitions."
  • "We will seek to capitalize on the substantial resources and the global infrastructure of Cantor and we believe the relationships of Cantor will provide us with exposure to a broad selection of potential acquisition targets."
  • "We do not believe that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination."
  • "We do not believe we will need to raise additional funds following this offering in order to meet our anticipated operating expenses."

Industry Context

The company operates as a Special Purpose Acquisition Company (SPAC) in a competitive market with a substantial increase in SPAC formations in recent years. This heightened competition may lead to target companies demanding improved financial terms, potentially increasing acquisition costs or complicating the search for suitable targets. The company aims to differentiate itself through its affiliation with Cantor Fitzgerald, L.P., a diversified financial and real estate services firm, and its management team's extensive experience in sourcing and executing acquisitions across various sectors, including financial services, digital assets, healthcare, real estate services, technology, and software. However, the past performance of Cantor's affiliated SPACs shows mixed results, with several experiencing high redemption rates or liquidation, indicating the inherent challenges in the SPAC market.

Comparison to Industry Standards

  • The company's structure, offering only Class A ordinary shares without warrants or rights, is presented as a way to reduce dilution compared to other SPACs that include such instruments.
  • Past performance of Prior Cantor SPACs (affiliated with the sponsor) shows mixed results and high redemption rates:
  • CFAC I (GCM Grosvenor Inc.): Stock price $11.79 (July 14, 2025), with 25.4% public shares redeemed for extensions and 33.5% for the business combination.
  • CFAC II (View, Inc.): Target taken private by creditors in Chapter 11 (May 2024), with 25.2% public shares redeemed for the business combination.
  • CFAC III (AEye, Inc.): Stock price $1.05 (July 14, 2025, after 30:1 reverse split), with 84.2% public shares redeemed for the business combination.
  • CFAC V (Satellogic, Inc.): Stock price $3.36 (July 14, 2025), with 92.6% public shares redeemed for the business combination.
  • CFAC VI (Rumble Inc.): Stock price $8.86 (July 14, 2025), with 0.1% public shares redeemed for the business combination.
  • CFAC VIII (XBP Europe, Inc.): Stock price $0.94 (July 14, 2025), with 97.2% public shares redeemed for extensions and 2.7% for the business combination.
  • CFAC IV: Liquidated in December 2023 after 84.9% public shares redeemed for extensions.
  • CFAC VII: Liquidated in December 2024 after 71.1% public shares redeemed for extensions.
  • The high redemption rates and liquidations of several affiliated SPACs suggest that their performance has been below the ideal outcome for public shareholders, indicating potential challenges in the SPAC model or target selection within the sponsor's ecosystem.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman and Chief Executive Officer (Cantor and CFGM)Howard W. LutnickBrandon Lutnick2025-02Howard W. Lutnick became the United States Secretary of Commerce.
Trustee of CFGM's sole stockholderHoward W. LutnickBrandon Lutnick (indirectly, via trusts)2025-05-16Agreements to sell voting shares of CFGM to trusts controlled by Brandon Lutnick.
Chief Financial Officer (Company)NAJane Novak2024-06Appointment to the role.
Director NomineeNADanny H. SalinasUpon commencement of trading of Class A ordinary shares on NasdaqAppointment to the board.
Director NomineeNADouglas R. BarnardUpon commencement of trading of Class A ordinary shares on NasdaqAppointment to the board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment

Legal Proceedings

  • No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team in their capacity as such.
  • Directors of CFAC II (a Prior Cantor SPAC) were named as defendants in a class action case alleging violation of federal securities laws, which was dismissed, reinstated as of June 12, 2024, when the court reconsidered its decision and dismissed the Cantor entities from the case, and is now on appeal to the 9th Circuit Court of Appeals.
  • Directors of CFAC II were also named as defendants in a class action case filed in the Delaware Court of Chancery alleging breach of fiduciary duty, which the parties have settled.
  • In December 2024, Cantor, without admitting or denying the underlying allegations, settled with the SEC by paying a $6.75 million penalty. The SEC alleged that the initial public offering and business combination registration statements and proxy statements of CFAC II and CFAC V contained misstatements regarding whether the respective SPACs had engaged in substantive discussions with potential targets prior to their respective initial public offerings, which statements the SEC Staff alleged Cantor caused the issuers to make.

Related Party Transactions

  • The sponsor, Cantor EP Holdings IV, LLC (wholly-owned by Cantor Fitzgerald, L.P.), purchased 11,500,000 Class B ordinary shares (founder shares) for a nominal price of $25,000 (approximately $0.002 per share).
  • The sponsor committed to purchase 900,000 private placement Class A ordinary shares for $9,000,000 ($10.00 per share) concurrently with the IPO.
  • CF&Co., an affiliate of the sponsor, is the sole book-running manager for the IPO and will receive an $8,000,000 underwriting discount.
  • CF&Co. will receive a business combination marketing fee of $14,000,000 (or up to $17,300,000 if the over-allotment option is exercised in full) upon the consummation of the initial business combination.
  • The company will pay the sponsor $10,000 per month for office space, administrative, and shared personnel support services.
  • The company will repay up to $300,000 in loans made by the sponsor to cover offering-related and organizational expenses. As of June 30, 2025, $59,507 was outstanding under this non-interest bearing loan.
  • The sponsor has committed a $1,750,000 non-interest bearing loan for working capital, which is convertible into Class A ordinary shares at $10.00 per share at the sponsor's option, no earlier than 60 days after the offering date.
  • Officers and directors, or their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with identifying, investigating, and completing an initial business combination.
  • Independent directors will receive cash fees of $50,000 per year, payable quarterly.
  • The company may engage CF&Co. or another affiliate of the sponsor as a financial advisor or placement agent for the business combination, with fees potentially conditioned upon completion.
  • Initial shareholders (sponsor, officers, and directors) will waive their redemption rights for founder and private placement shares and agree to vote in favor of any proposed initial business combination.
  • On May 16, 2025, Howard W. Lutnick entered into agreements to sell voting shares of CFGM (managing general partner of Cantor) to trusts controlled by Brandon Lutnick, transferring beneficial ownership influence.

Stakeholder Impact

  • **Shareholders (Public)**: Will face immediate and substantial dilution (over 100%) due to the sponsor's low-cost founder shares. Their redemption rights are subject to limitations, including a 15% cap without prior consent, which may reduce their influence over business combination approvals. There is a risk of losing their investment if a business combination is not completed within the specified timeframe.
  • **Shareholders (Sponsor/Initial)**: Stand to make a substantial profit on their investment even if the stock price declines significantly post-business combination due to their nominal purchase price for founder shares. They control director appointments prior to the business combination and exert significant voting influence on corporate actions.
  • **Management/Directors**: Have potential conflicts of interest due to their affiliations with Cantor and other SPACs, and financial incentives tied to the completion of a business combination. They will be reimbursed for expenses, and independent directors receive annual fees.
  • **Creditors**: Claims by third parties could potentially reduce the amount of funds available in the trust account for public shareholder redemptions if not waived. The sponsor has agreed to indemnify the company against certain claims, but its ability to satisfy these obligations is not guaranteed.
  • **Underwriters (CF&Co.)**: Will receive an $8,000,000 underwriting discount and a significant business combination marketing fee ($14,000,000 to $17,300,000) contingent on the completion of a business combination, creating a strong incentive for them to see a transaction close.

Next Steps

  • Complete the initial public offering of Class A ordinary shares and list them on the Nasdaq Global Market under the symbol CEPF.
  • Identify and evaluate potential target businesses for an initial business combination within 24 months from the closing of the offering.
  • Conduct thorough due diligence on prospective target businesses and negotiate a definitive agreement for an initial business combination.
  • Seek shareholder approval for an initial business combination if required by law or stock exchange rules, or if decided for business/legal reasons.
  • Potentially seek shareholder approval to amend the memorandum and articles of association to extend the business combination deadline if needed.
  • Repay up to $300,000 in loans from the sponsor for offering-related expenses upon closing of the IPO.
  • Repay (or convert into Class A ordinary shares) the $1,750,000 working capital loan from the sponsor upon consummation of the initial business combination.
  • Appoint two additional independent directors to the audit committee during the one-year period following the listing on Nasdaq.
  • Comply with the internal control requirements of the Sarbanes-Oxley Act for the fiscal year ending December 31, 2026.

Key Dates

DateDescription
2021-04-30Company incorporated as a Cayman Islands exempted company.
2021-04Sponsor purchased 14,375,000 Class B ordinary shares for $25,000.
2021-07Jane Novak served as CFO of CFAC III, CFAC V, CFAC VI, CFAC VIII, and CFAC IV.
2021-08CFAC II consummated initial public offering.
2021-11CFAC III consummated initial public offering.
2021-11-01BGC successfully completed the sale of its insurance brokerage business for approximately $535 million.
2021-12CFAC IV consummated initial public offering.
2021-12CFAC VII consummated initial public offering.
2022-01CFAC V consummated initial public offering.
2022-04Brandon Lutnick joined Cantor.
2022-09CFAC VI consummated initial business combination with Rumble Inc.
2022-12Douglas Barnard served as a director of CFAC VII.
2023-03-10FDIC announced Silicon Valley Bank closure.
2023-09Danny H. Salinas joined Cantor as Senior Managing Director and Chief Financial Officer.
2023-11CFAC VIII consummated initial business combination with XBP Europe, Inc.
2023-12CFAC III reverse stock split (30 to 1).
2023-12CFAC IV liquidated.
2024-01-01Company adopted ASU No. 2023-07 (Segment Reporting).
2024-03FASB issued ASU No. 2024-02 (Codification Improvements).
2024-05Jane Novak served as CFO of CEP I.
2024-05View, Inc. (CFAC II target) taken private by creditors in Chapter 11 restructuring.
2024-06-06Sponsor surrendered 9,375,000 Class B ordinary shares for no consideration.
2024-06Sponsor agreed to loan the Company up to $300,000.
2024-08CEP consummated initial public offering.
2024-08Danny H. Salinas served as a director of CEP.
2024-11FASB issued ASU No. 2024-03 (Income Statement Expense Disaggregation Disclosures).
2024-12CFAC VII liquidated.
2024-12Cantor settled with SEC, paying a $6.75 million penalty for alleged misstatements in CFAC II and CFAC V registration statements.
2025-01-01Company applies ASU No. 2023-07 guidance for interim periods.
2025-01-01New guidance for ASU No. 2024-02 became effective for the Company.
2025-01Brandon Lutnick served as Chairman and CEO of CEP II and CEP III.
2025-01Danny H. Salinas served as a director of CEP I, CEP II, and CEP III.
2025-01Douglas Barnard served as a director of CEP I.
2025-01CEP I consummated initial public offering.
2025-02Brandon Lutnick became Chairman and Chief Executive Officer of Cantor and CFGM.
2025-04-22CEP entered into a business combination agreement with Twenty One Capital, Inc.
2025-05CEP II consummated initial public offering.
2025-05-16Howard W. Lutnick entered into agreements to sell voting shares of CFGM to trusts controlled by Brandon Lutnick.
2025-05FASB issued ASU No. 2025-03 (Business Combinations and Consolidation).
2025-06CEP III consummated initial public offering.
2025-06-17Company issued 6,500,000 Class B ordinary shares to the Sponsor in a share capitalization.
2025-06-30Balance Sheet Data as of this date.
2025-07-14Stock prices for GCM Grosvenor ($11.79), AEye ($1.05), Satellogic ($3.36), Rumble ($8.86), XBP Europe ($0.94) reported.
2025-07-16CEP I entered into a business combination agreement with BSTR Holdings, Inc.
2025-07-18Date of auditor's report for financial statements as of and for the years ended December 31, 2024 and 2023.
2025-08-08Filing date of Amendment No. 1 to Form S-1.
2025-08-08Financial statements available to be issued.
2025-08Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.
2025-08Class A ordinary shares expected to be listed on Nasdaq on or promptly after this date.
2027-01-01New guidance for ASU No. 2024-03 (Income Statement Expense Disaggregation Disclosures) becomes effective for annual reporting periods.
2027-01-01New guidance for ASU No. 2025-03 (Business Combinations and Consolidation) becomes effective for interim and annual reporting periods.
2027-06-30Promissory note from sponsor due by this date or closing of IPO, whichever is earlier.
2028-01-01New guidance for ASU No. 2024-03 (Income Statement Expense Disaggregation Disclosures) becomes effective for interim reporting periods.

Recommendation

sell

The filing reveals significant immediate dilution for public shareholders (over 100%) due to the sponsor's acquisition of founder shares at a nominal price ($0.002 per share), creating a substantial misalignment of incentives. The sponsor stands to profit significantly even if the stock price declines post-business combination, while public shareholders bear the brunt of the risk. Furthermore, the history of several affiliated SPACs showing high redemption rates and liquidations indicates a pattern of unfavorable outcomes for public investors. The extensive conflicts of interest involving management and affiliates, coupled with the company's blank check nature and lack of operating history, present a high degree of risk and uncertainty for public shareholders. The potential for a 1% excise tax on redemptions further detracts from investor returns. Given these factors, a seasoned investor would likely recommend selling to avoid the inherent risks and unfavorable terms.

Keywords

SPAC, Special Purpose Acquisition Company, IPO, Blank Check Company, Cantor Equity Partners IV, Financial Services, Digital Assets, Healthcare, Real Estate Services, Technology, Software, Business Combination, Acquisition, SEC Filing, S-1/A, Dilution, Conflicts of Interest, Trust Account, Redemption Rights, Corporate Governance, Nasdaq Listing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.